Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition of killed cells with substantially retained immunogenicity

Pharmaceutical composition of killed cells with substantially retained immunogenicity

US Patent 9795659 · Granted Oct 24, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic cancer vaccine2022
Therapeutic cancer vaccine2022
Synthesis of novel intermediate(s) for preparing rivastigmine2021
Synthesis of novel intermediate(s) for preparing rivastigmine2021
Therapeutic cancer vaccine2019
Therapeutic cancer vaccine2019
Stable pharmaceutical composition for atherosclerosis2017
Stable pharmaceutical composition for atherosclerosis2017
Cancer antigen2017
Cancer antigen2017
Indole 3-carbinol derivatives2017
Pharmaceutical compositions of curcumin2016